糖尿病
Online ISSN : 1881-588X
Print ISSN : 0021-437X
ISSN-L : 0021-437X
Monocomponent Insulin製剤中の低プロインスリン様活性について
天工 厚子尾山 秀樹中島 行正松村 茂一西田 聖幸堀野 正治
著者情報
ジャーナル フリー

1977 年 20 巻 4 号 p. 492-494

詳細
抄録

Conventional insulin preparations (Novo), 5 times recrystallized, were contaminated with approximately 1 to 2 % proinsulin-like substances. Anti-insulin antibodies and even proinsulin-specific antibodies were found in many cases of diabetics treated with these insulin preparations. Monocomponent insulin, purified in order to eliminate its antigenicity for insulin, appeared to be less immunogenic than conventional insulin.
In this study, the contaminating proinsulin-like substances in Monocomponent Lente insulin (Batch 522*5), Monocomponent Actrapid insulin (Batch 500*5) and conventional Lente insulin (Lot. No.297961) were estimated directly and after gel filtration by porcine proinsulin-speufic specific radioimmunoassay.
Although gel filtration of conventional insulin (500 ng) revealed proinsulin-like components (PLC), these PLC were not detectable after gel filtration of 500 ng and 5000 ng of Monocomponent insulin by specific radioimmunoassay.
Monocomponent insulin preparations contained less than O.0001% of porcine proinsulin-like immunoreactivity (PLI) by weight as estimated directly utilizing specific radioimmunoassay for porcine PLI.

著者関連情報
© 社団法人 日本糖尿病学会
前の記事 次の記事
feedback
Top